» Articles » PMID: 2585132

Phosphorus-induced Nephrocalcinosis and Kidney Function in Female Rats

Overview
Journal J Nutr
Publisher Elsevier
Date 1989 Oct 1
PMID 2585132
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The question was addressed whether dietary phosphorus-induced nephrocalcinosis in rats is associated with impaired kidney function. Weanling female rats were fed purified diets containing either 0.4 or 0.6% (wt/wt) phosphorus for 28 d. The diet containing 0.6% phosphorus produced marked kidney calcification, as determined both by chemical analysis of kidney calcium and histological examination in kidney sections. Histological examination did not show calcification in stomach, lung, heart or thoracic aorta, which are predisposition sites of metastatic calcification in secondary renal hyperparathyroidism. In rats fed the 0.6% phosphorus diet, phosphorus retention and urinary excretion were greater compared with rats fed the 0.4% phosphorus diet. The following indicators of kidney function were examined: water intake, urinary volume, urine and plasma osmolality, urine and plasma creatinine, urine and plasma urea, urea and creatinine clearance and urinary albumin excretion. Of these indicators, only urinary albumin excretion was significantly increased in rats fed the nephrocalcinogenic diet. In a further experiment, the increase of urinary albumin was reproduced. After pooling the results of the two experiments, in individual rats fed the 0.6% phosphorus diet, the concentration of kidney calcium was found to be positively related with kidney weight expressed relative to body weight (r = 0.82, n = 22) and with albumin excretion in urine (r = 0.79, n = 28). The increased weight of calcinotic kidneys was mainly due to both calcium deposition and tubular hyperplasia. It is concluded that dietary phosphorus-induced nephrocalcinosis is associated with impaired kidney function in rats.

Citing Articles

Re-evaluation of calcium carbonate (E 170) as a food additive in foods for infants below 16 weeks of age and follow-up of its re-evaluation as food additive for uses in foods for all population groups.

Younes M, Aquilina G, Castle L, Degen G, Engel K, Fowler P EFSA J. 2023; 21(7):e08106.

PMID: 37522100 PMC: 10373136. DOI: 10.2903/j.efsa.2023.8106.


Structural and ultrastructural renal lesions in rats fed high-fat and high-phosphorus diets.

Esquinas P, Rios R, Raya A, Pineda C, Rodriguez M, Aguilera-Tejero E Clin Kidney J. 2021; 14(3):847-854.

PMID: 33777367 PMC: 7986333. DOI: 10.1093/ckj/sfaa009.


Re-evaluation of phosphoric acid-phosphates - di-, tri- and polyphosphates (E 338-341, E 343, E 450-452) as food additives and the safety of proposed extension of use.

Younes M, Aquilina G, Castle L, Engel K, Fowler P, Frutos Fernandez M EFSA J. 2020; 17(6):e05674.

PMID: 32626329 PMC: 7009158. DOI: 10.2903/j.efsa.2019.5674.


Re-evaluation of oxidised starch (E 1404), monostarch phosphate (E 1410), distarch phosphate (E 1412), phosphated distarch phosphate (E 1413), acetylated distarch phosphate (E 1414), acetylated starch (E 1420), acetylated distarch adipate (E 1422),....

Mortensen A, Aguilar F, Crebelli R, Di Domenico A, Dusemund B, Frutos M EFSA J. 2020; 15(10):e04911.

PMID: 32625282 PMC: 7009865. DOI: 10.2903/j.efsa.2017.4911.


Hyperparathyroidism and increased fractional excretion of phosphate predict allograft loss in long-term kidney transplant recipients.

Prakobsuk S, Sirilak S, Vipattawat K, Taweesedt P, Sumethkul V, Kantachuvesiri S Clin Exp Nephrol. 2016; 21(5):926-931.

PMID: 27981393 DOI: 10.1007/s10157-016-1370-9.